{ "schemaVersion": 2, "eyebrow": "Psychiatry", "title": "Panic Disorder", "summary": "Evaluate acute cardiopulmonary, respiratory, toxicologic, and substance-related mimics before diagnosing panic disorder. Confirm recurrent unexpected attacks plus persistent concern or avoidance, then select disorder-focused CBT, an SSRI or SNRI, or both according to severity, preference, access, and comorbidity.", "seoDescription": "Physician guide to panic disorder: emergency exclusion of medical mimics, diagnostic confirmation, validated rating tools, CBT, and medication selection.", "clinicalQuestion": "How should clinicians exclude dangerous mimics, confirm panic disorder, and choose evidence-supported treatment?", "specialty": "Psychiatry", "audience": "U.S. physicians and medical trainees", "tags": [ "panic disorder", "panic attacks", "agoraphobia", "cognitive behavioral therapy", "Panic Disorder Severity Scale", "emergency psychiatry" ], "keyTakeaways": [ "In acute presentations, assess cardiopulmonary and respiratory causes and drug exposure before assigning panic disorder; point-of-care lung ultrasonography, chest radiography, peak flowmetry, and toxicology screening are specifically described emergency tests. [23]", "Panic disorder requires recurrent unexpected panic attacks plus at least 1 month of persistent attack-related concern, worry, or maladaptive behavioral change; agoraphobia is diagnostically distinct. [24]", "Use a structured severity measure such as the Panic Disorder Severity Scale to establish baseline burden and monitor response. [23]", "CBT has sustained benefit versus control conditions for panic disorder at 1 to 6 months and 6 to 12 months after treatment completion. [4]", "Guidelines reviewed across anxiety disorders identify SSRIs or SNRIs as first-line pharmacotherapy; benzodiazepines, TCAs, and other agents are not first-line choices. [13]" ], "sections": [ { "id": "acute-presentation", "eyebrow": "Emergency assessment", "heading": "Do not diagnose panic disorder before excluding acute medical illness", "intro": "Stabilize and investigate according to the presenting symptom complex rather than attributing chest pain or dyspnea to anxiety.", "paragraphs": [ "For an acute episode with chest discomfort, dyspnea, wheeze, syncope, or marked autonomic symptoms, perform a focused cardiopulmonary and substance-exposure assessment before making a psychiatric diagnosis. Emergency evaluation may include point-of-care lung ultrasonography, bedside chest radiography, and peak flowmetry to identify respiratory abnormalities; obtain toxicology screening when drug misuse or intoxication is plausible. [23]", "A panic attack has abrupt onset, peaks within 10 minutes, and is characterized by at least 4 physical or cognitive symptoms; an episode commonly lasts about 1 hour. This temporal pattern supports, but does not establish, a panic diagnosis because acute medical disorders can present with similar symptoms. [23]", "After acute physical causes have been evaluated, document the event phenotype, triggers, frequency, avoidance, current medications, and substance use. A symptom score can quantify burden but cannot replace medical exclusion or longitudinal diagnostic assessment. [23]" ], "bullets": [ "Use bedside lung ultrasonography, chest radiography, and peak flowmetry when respiratory pathology is in the acute differential. [23]", "Order toxicology screening when stimulant, other substance, or medication-related symptoms are possible. [23]", "Do not use a brief emergency presentation alone to establish the longitudinal persistence criterion for panic disorder. [23][24]" ], "subsections": [], "table": { "caption": "Acute branches that determine the next diagnostic action. [23]", "columns": [ "Presentation pattern", "Immediate diagnostic action", "Interpretation and next step" ], "rows": [ [ "Dyspnea, wheeze, or suspected respiratory abnormality", "Point-of-care lung ultrasonography, bedside chest radiography, and peak flowmetry. [23]", "Treat or further evaluate identified respiratory disease; diagnose panic disorder only after physical causes are addressed. [23]" ], [ "Symptoms with possible substance exposure", "Toxicology screening. [23]", "If exposure is identified, assess a substance- or medication-related cause before assigning primary panic disorder. [23]" ], [ "Abrupt fear with autonomic and cognitive symptoms", "Characterize onset, peak, symptom count, recurrence, and post-attack behavior. [23][24]", "Rapid peak supports a panic attack phenotype; recurrent unexpected attacks plus persistent sequelae are required for panic disorder. [23][24]" ] ] } }, { "id": "diagnostic-confirmation", "eyebrow": "Longitudinal diagnosis", "heading": "Confirm panic disorder and separate agoraphobic avoidance", "intro": "The diagnostic pivot is recurrence of unexpected attacks followed by durable concern or behavior change.", "paragraphs": [ "Diagnose panic disorder when recurrent unexpected panic attacks are accompanied by at least 1 month of persistent concern, worry, or behavioral change related to attacks. The post-attack persistence requirement distinguishes a recurrent disorder from an isolated panic attack. [24]", "Assess agoraphobia separately. DSM-5 distinguishes agoraphobia from panic disorder, so document avoidance and its functional effect rather than treating agoraphobic behavior as automatically establishing panic disorder. [24]", "Measure baseline severity with the Panic Disorder Severity Scale, Panic Disorder Self-Report, Panic and Agoraphobia Scale, NIMH Panic Questionnaire, or Panic-Associated Symptoms Scale. The Panic Disorder Severity Scale is among tools identified for physician use in emergency and primary-care settings. [23]" ], "bullets": [ "Record whether attacks are unexpected versus situationally cued; the disorder criterion specifies recurrent unexpected attacks. [24]", "Ask whether attack-related concern, catastrophic worry, or avoidance has persisted for at least 1 month. [24]", "Document agoraphobia as a separate diagnostic and treatment target. [24]" ], "subsections": [], "table": { "caption": "Diagnostic elements that change classification and management. [23][24]", "columns": [ "Finding", "Clinical interpretation", "Action" ], "rows": [ [ "Single or recurrent episodes without documented 1-month sequelae", "A panic attack phenotype may be present, but the persistence criterion for panic disorder is not established. [23][24]", "Continue medical and longitudinal assessment; avoid prematurely labeling panic disorder. [24]" ], [ "Recurrent unexpected attacks plus ≥1 month of worry, concern, or behavioral change", "Meets the operational DSM-5 description of panic disorder. [24]", "Establish severity baseline and initiate disorder-focused treatment. [23][24]" ], [ "Avoidance consistent with agoraphobia", "Agoraphobia is distinguished from panic disorder in DSM-5. [24]", "Document separately and incorporate avoidance-focused treatment goals. [24]" ] ] } }, { "id": "treatment-selection", "eyebrow": "Definitive treatment", "heading": "Choose CBT, first-line antidepressant therapy, or both", "intro": "Select treatment by patient preference, access, symptom burden, avoidance, comorbidity, and prior treatment response.", "paragraphs": [ "Offer cognitive behavioral therapy as an evidence-based treatment pathway. In a systematic review and meta-analysis of 69 randomized trials involving 4,118 outpatients with anxiety-related disorders, CBT was associated with better panic-disorder outcomes than control conditions after treatment and at 1 to 6 months and 6 to 12 months of follow-up; reported Hedges g values for panic disorder were 0.22 to 0.35. [4]", "When medication is chosen, use an SSRI or SNRI as first-line pharmacotherapy. An umbrella review of antipsychotic agents in anxiety disorders reports that treatment guidelines recommend SSRIs or SNRIs first line, whereas benzodiazepines, TCAs, and other agents are not first-line pharmacotherapy. [13]", "For patients preferring psychodynamic treatment or unable to engage in CBT, panic-focused psychodynamic psychotherapy has randomized-trial evidence versus applied relaxation training, but its comparative effectiveness against CBT and medications remains unresolved. [6] Do not substitute an untested modality for CBT or a first-line antidepressant without clarifying that evidence limitation." ], "bullets": [ "Use CBT when the patient prefers psychotherapy, has prominent avoidance, or wants a nonpharmacologic first-line option; outcomes remained superior to control conditions through 12 months after completion. [4]", "Use an SSRI or SNRI when pharmacotherapy is preferred or indicated by clinical context; reassess tolerability and response rather than escalating to non-first-line classes by default. [13]", "Consider panic-focused psychodynamic psychotherapy as an alternative psychotherapy option, while counseling that direct comparisons with CBT and medications are needed. [6]" ], "subsections": [ { "heading": "Avoid reflexive antipsychotic use", "paragraphs": [ "Do not use an antipsychotic as routine first-line pharmacotherapy for panic disorder. Guideline recommendations summarized in an umbrella review place SSRIs and SNRIs first line and classify benzodiazepines, TCAs, and other agents outside that first-line position. [13]" ], "bullets": [] } ], "table": { "caption": "Treatment-selection framework for confirmed panic disorder. [4][6][13]", "columns": [ "Clinical situation", "Preferred next step", "Key tradeoff" ], "rows": [ [ "Patient prefers psychotherapy or has a strong avoidance target", "Offer CBT. [4]", "CBT showed benefit versus control conditions through 6 to 12 months after treatment completion. [4]" ], [ "Patient prefers medication or requires pharmacotherapy", "Start an SSRI or SNRI as first-line pharmacotherapy. [13]", "Monitor response and tolerability before moving to non-first-line medication classes. [13]" ], [ "CBT is unavailable, unacceptable, or not feasible", "Discuss panic-focused psychodynamic psychotherapy as an alternative. [6]", "Evidence exists versus applied relaxation training, but comparative evidence against CBT and medications is still needed. [6]" ], [ "Considering antipsychotic, benzodiazepine, or TCA as initial treatment", "Reassess the treatment plan; these are not identified as first-line pharmacotherapy in guideline summaries. [13]", "Reserve non-first-line approaches for individualized circumstances rather than routine initial management. [13]" ] ] } }, { "id": "monitoring-and-nonresponse", "eyebrow": "Follow-up", "heading": "Measure response and reassess the diagnosis before changing treatment", "intro": "Track attack burden, anticipatory anxiety, avoidance, function, adverse effects, adherence, and alternative explanations at each treatment decision.", "paragraphs": [ "Use the same structured measure at baseline and follow-up when possible, particularly the Panic Disorder Severity Scale or a panic-specific self-report instrument. This makes change in panic frequency, symptom burden, and agoraphobic avoidance visible rather than relying solely on an unstructured global impression. [23]", "When response is inadequate, first reassess adherence, diagnostic accuracy, and comorbidities before changing therapy. Across adult depression guidelines, this sequence was a common initial recommendation for inadequate first-line treatment and is a useful safeguard against premature medication switching in patients with persistent panic-like symptoms. [3]", "Reopen the medical differential when the symptom pattern changes, new cardiopulmonary or respiratory findings emerge, or substance exposure becomes plausible. Repeat targeted evaluation rather than attributing all subsequent episodes to a prior panic diagnosis. [23]" ], "bullets": [ "At each visit, record panic frequency, attack-related worry, avoidance, function, treatment adherence, and adverse effects using a consistent instrument. [23]", "Before declaring treatment failure, reassess diagnosis, adherence, and comorbid conditions. [3]", "Escalate or repeat medical evaluation for a changed acute phenotype rather than assuming recurrence of panic disorder. [23]" ], "subsections": [], "table": { "caption": "Follow-up decisions after treatment initiation. [3][23]", "columns": [ "Follow-up finding", "Next action", "Reason" ], "rows": [ [ "Improvement on baseline panic measure", "Continue the effective treatment plan and continue structured symptom monitoring. [23]", "A panic-specific tool provides a reproducible measure of change. [23]" ], [ "Persistent symptoms with uncertain adherence, diagnosis, or comorbidity", "Assess adherence, reassess diagnosis, and evaluate comorbidities before changing first-line treatment. [3]", "These were common first steps across reviewed inadequate-response guidelines. [3]" ], [ "New or changed dyspnea, chest, respiratory, or substance-related features", "Repeat targeted acute medical evaluation, including respiratory testing or toxicology screening when indicated. [23]", "Physical and substance-related causes require reassessment before psychiatric attribution. [23]" ] ] } } ], "faq": [], "references": [ { "number": 1, "title": "[PDF] NDA 215455 - FDA", "detail": "www.fda.gov", "url": "https://www.fda.gov/media/178984/download", "authors": "www.fda.gov", "host": "www.fda.gov" }, { "number": 2, "title": "[PDF] Prozac (fluoxetine hydrochloride) 10 mg, 20 ... - accessdata.fda.gov", "detail": "www.accessdata.fda.gov", "url": "https://www.accessdata.fda.gov/drugsatfda_docs/nda/2011/021235Orig1s016.pdf", "authors": "www.accessdata.fda.gov", "host": "www.accessdata.fda.gov" }, { "number": 3, "title": "Quality of clinical practice guidelines for inadequate response to first-line treatment for depression according to AGREE II checklist and comparison of recommendations: a systematic review | BMJ Open", "detail": "bmjopen.bmj.com", "url": "https://bmjopen.bmj.com/content/12/4/e051918", "authors": "bmjopen.bmj.com", "host": "bmjopen.bmj.com" }, { "number": 4, "title": "Long-term Outcomes of Cognitive Behavioral Therapy for Anxiety-Related Disorders: A Systematic Review and", "detail": "jamanetwork.com", "url": "https://jamanetwork.com/journals/jamapsychiatry/fullarticle/2756136", "authors": "jamanetwork.com", "host": "jamanetwork.com" }, { "number": 5, "title": "Which psychotherapy is effective in panic disorder? And which delivery formats are supported by the evidence? Study protocol for two systematic reviews and network meta-analyses", "detail": "bmjopen.bmj.com", "url": "https://bmjopen.bmj.com/content/10/12/e038909", "authors": "bmjopen.bmj.com", "host": "bmjopen.bmj.com" }, { "number": 6, "title": "Psychodynamic Psychotherapy for Panic Disorder? | NEJM Clinician", "detail": "clinician.nejm.org", "url": "https://clinician.nejm.org/psychodynamic-psychotherapy-panic-disorder-JP200703120000001", "authors": "clinician.nejm.org", "host": "clinician.nejm.org" }, { "number": 7, "title": "Screening for Anxiety in Adolescent and Adult Women - ACP Journals", "detail": "www.acpjournals.org", "url": "https://www.acpjournals.org/doi/10.7326/M20-0579", "authors": "www.acpjournals.org", "host": "www.acpjournals.org" }, { "number": 8, "title": "Management of Chronic Insomnia Disorder in Adults - ACP Journals", "detail": "www.acpjournals.org", "url": "https://www.acpjournals.org/doi/10.7326/M15-2175", "authors": "www.acpjournals.org", "host": "www.acpjournals.org" }, { "number": 9, "title": "The quality and clinical applicability of recommendations in anxiety disorders guidelines: A systematic review of seventeen guidelines from seven countries - ScienceDirect", "detail": "www.sciencedirect.com", "url": "https://www.sciencedirect.com/science/article/pii/S0165032721009083", "authors": "www.sciencedirect.com", "host": "www.sciencedirect.com" }, { "number": 10, "title": "Couple therapy and systemic interventions for adult‐focused ...", "detail": "onlinelibrary.wiley.com", "url": "https://onlinelibrary.wiley.com/doi/10.1111/1467-6427.12481", "authors": "onlinelibrary.wiley.com", "host": "onlinelibrary.wiley.com" }, { "number": 11, "title": "Panic Disorder and Migraine: Comorbidity, Mechanisms, and ...", "detail": "headachejournal.onlinelibrary.wiley.com", "url": "https://headachejournal.onlinelibrary.wiley.com/doi/10.1111/head.12004", "authors": "headachejournal.onlinelibrary.wiley.com", "host": "headachejournal.onlinelibrary.wiley.com" }, { "number": 12, "title": "The identification and psychological treatment of panic disorder in ...", "detail": "acamh.onlinelibrary.wiley.com", "url": "https://acamh.onlinelibrary.wiley.com/doi/pdf/10.1111/camh.12372", "authors": "acamh.onlinelibrary.wiley.com", "host": "acamh.onlinelibrary.wiley.com" }, { "number": 13, "title": "Antipsychotic agents in anxiety disorders: An umbrella review", "detail": "onlinelibrary.wiley.com", "url": "https://onlinelibrary.wiley.com/doi/full/10.1111/acps.13669", "authors": "onlinelibrary.wiley.com", "host": "onlinelibrary.wiley.com" }, { "number": 14, "title": "A Network Analysis of Panic Disorder, Agoraphobia, and ...", "detail": "onlinelibrary.wiley.com", "url": "https://onlinelibrary.wiley.com/doi/10.1002/brb3.71241", "authors": "onlinelibrary.wiley.com", "host": "onlinelibrary.wiley.com" }, { "number": 15, "title": "Evaluating the efficacy of psychological therapies for generalised ...", "detail": "acamh.onlinelibrary.wiley.com", "url": "https://acamh.onlinelibrary.wiley.com/doi/10.1002/jcv2.70056", "authors": "acamh.onlinelibrary.wiley.com", "host": "acamh.onlinelibrary.wiley.com" }, { "number": 16, "title": "Diagnosis and treatment of patients with bipolar disorder", "detail": "onlinelibrary.wiley.com", "url": "https://onlinelibrary.wiley.com/doi/pdf/10.1002/2327-6924.12275", "authors": "onlinelibrary.wiley.com", "host": "onlinelibrary.wiley.com" }, { "number": 17, "title": "Cardiac Anxiety - an overview | ScienceDirect Topics", "detail": "www.sciencedirect.com", "url": "https://www.sciencedirect.com/topics/neuroscience/cardiac-anxiety", "authors": "www.sciencedirect.com", "host": "www.sciencedirect.com" }, { "number": 18, "title": "A meta-analysis of the efficacy of psycho- and pharmacotherapy in panic disorder with and without agoraphobia - ScienceDirect", "detail": "www.sciencedirect.com", "url": "https://www.sciencedirect.com/science/article/pii/S0165032705001278", "authors": "www.sciencedirect.com", "host": "www.sciencedirect.com" }, { "number": 19, "title": "Table A4, Characteristics of Included Guidelines - Yoga for the Treatment of Post-Traumatic Stress Disorder, Generalized Anxiety Disorder, Depression, and Substance Abuse: A Review of the Clinical Effectiveness and Guidelines - NCBI Bookshelf", "detail": "www.ncbi.nlm.nih.gov", "url": "https://www.ncbi.nlm.nih.gov/books/NBK304568/table/T5?report=objectonly", "authors": "www.ncbi.nlm.nih.gov", "host": "www.ncbi.nlm.nih.gov" }, { "number": 20, "title": "Table 1, Current clinical practice guidelines for the treatment of child and adolescent DDs - Treatment of Depression in Children and Adolescents: A Systematic Review - NCBI Bookshelf", "detail": "www.ncbi.nlm.nih.gov", "url": "https://www.ncbi.nlm.nih.gov/books/NBK555846/table/ch2.tab1", "authors": "www.ncbi.nlm.nih.gov", "host": "www.ncbi.nlm.nih.gov" }, { "number": 21, "title": "Table 4, Characteristics of Included Guidelines - Short-Term Psychodynamic Psychotherapy for the Treatment of Mental Illness: A Review of Clinical Effectiveness and Guidelines - NCBI Bookshelf", "detail": "www.ncbi.nlm.nih.gov", "url": "https://www.ncbi.nlm.nih.gov/books/NBK525874/table/app2.t3?report=objectonly", "authors": "www.ncbi.nlm.nih.gov", "host": "www.ncbi.nlm.nih.gov" }, { "number": 22, "title": "Clinical Guidelines on Long-Term Pharmacotherapy for Bipolar Disorder in Children and Adolescents - PMC", "detail": "www.ncbi.nlm.nih.gov", "url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4449672?term=", "authors": "www.ncbi.nlm.nih.gov", "host": "www.ncbi.nlm.nih.gov" }, { "number": 23, "title": "Clinical Practice Guidelines for Assessment and Management of ...", "detail": "pmc.ncbi.nlm.nih.gov", "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC10096212", "authors": "pmc.ncbi.nlm.nih.gov", "host": "pmc.ncbi.nlm.nih.gov" }, { "number": 24, "title": "Panic Disorder: Current Research and Management Approaches - PMC", "detail": "pmc.ncbi.nlm.nih.gov", "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC6354045", "authors": "pmc.ncbi.nlm.nih.gov", "host": "pmc.ncbi.nlm.nih.gov" } ], "editorialNote": "Prepared from cited clinical literature using Astra's research workflow. Verify recommendations against current guidance and patient-specific factors.", "citations": [ { "number": 1, "title": "[PDF] NDA 215455 - FDA", "detail": "www.fda.gov", "url": "https://www.fda.gov/media/178984/download", "authors": "www.fda.gov", "host": "www.fda.gov", "snippet": "modalities of psychotherapy (such as cognitive-behavioral therapy [CBT] or eye movement desensitization and reprocessing [EMDR]) either alone or in combination with pharmacotherapy. • There are only two currently approved pharmacotherapeutic treatments for PTSD, sertraline and paroxetine, both appro", "score": 0.4751919 }, { "number": 2, "title": "[PDF] Prozac (fluoxetine hydrochloride) 10 mg, 20 ... - accessdata.fda.gov", "detail": "www.accessdata.fda.gov", "url": "https://www.accessdata.fda.gov/drugsatfda_docs/nda/2011/021235Orig1s016.pdf", "authors": "www.accessdata.fda.gov", "host": "www.accessdata.fda.gov", "snippet": "observation for relapse. Response during the single-blind phase was defined by having achieved at least a 50% decrease in vomiting frequency compared with baseline. Relapse during the double-blind phase was defined as a persistent return to baseline vomiting frequency or physician judgment that the ", "score": 0.44811285 }, { "number": 3, "title": "Quality of clinical practice guidelines for inadequate response to first-line treatment for depression according to AGREE II checklist and comparison of recommendations: a systematic review | BMJ Open", "detail": "bmjopen.bmj.com", "url": "https://bmjopen.bmj.com/content/12/4/e051918", "authors": "bmjopen.bmj.com", "host": "bmjopen.bmj.com", "snippet": "in adults: recognition and management from the National Institute for Health and Care Excellence (NICE)—UK, score=84%26; Depression, Adults in Primary Care from Institute for Clinical Systems Improvement (ICSI) Healthcare Guideline—US, score=81%27; CPG for the Treatment of Depression across Three Ag", "score": 0.35911742 }, { "number": 4, "title": "Long-term Outcomes of Cognitive Behavioral Therapy for Anxiety-Related Disorders: A Systematic Review and", "detail": "jamanetwork.com", "url": "https://jamanetwork.com/journals/jamapsychiatry/fullarticle/2756136", "authors": "jamanetwork.com", "host": "jamanetwork.com", "snippet": "**Findings**In this systematic review and meta-analysis of 69 randomized clinical trials including 4118 patients, cognitive behavioral therapy was associated with better outcomes compared with control conditions among patients with anxiety symptoms within 12 months after treatment completion. **Obje", "score": 0.8319231 }, { "number": 5, "title": "Which psychotherapy is effective in panic disorder? And which delivery formats are supported by the evidence? Study protocol for two systematic reviews and network meta-analyses", "detail": "bmjopen.bmj.com", "url": "https://bmjopen.bmj.com/content/10/12/e038909", "authors": "bmjopen.bmj.com", "host": "bmjopen.bmj.com", "snippet": "Title: Which psychotherapy is effective in panic disorder? And which delivery formats are supported by the evidence? Study protocol for two systematic reviews and network meta-analyses\nIn this protocol, we present an overarching project consisting of two systematic reviews and network meta-analyses ", "score": 0.7555112 }, { "number": 6, "title": "Psychodynamic Psychotherapy for Panic Disorder? | NEJM Clinician", "detail": "clinician.nejm.org", "url": "https://clinician.nejm.org/psychodynamic-psychotherapy-panic-disorder-JP200703120000001", "authors": "clinician.nejm.org", "host": "clinician.nejm.org", "snippet": "Psychoanalytic psychotherapists have long argued that their therapies are effective for panic disorder, but these claims have hitherto lacked the quality of evidence required by current standards. In this randomized, controlled clinical trial, 49 adults with DSM-IV panic disorder (mean number of Axi", "score": 0.529045 }, { "number": 7, "title": "Screening for Anxiety in Adolescent and Adult Women - ACP Journals", "detail": "www.acpjournals.org", "url": "https://www.acpjournals.org/doi/10.7326/M20-0579", "authors": "www.acpjournals.org", "host": "www.acpjournals.org", "snippet": "The purpose of this systematic review is to evaluate evidence on the effectiveness of screening for anxiety disorders in improving symptoms,", "score": 0.30250487 }, { "number": 8, "title": "Management of Chronic Insomnia Disorder in Adults - ACP Journals", "detail": "www.acpjournals.org", "url": "https://www.acpjournals.org/doi/10.7326/M15-2175", "authors": "www.acpjournals.org", "host": "www.acpjournals.org", "snippet": "This guideline is based on a systematic review of randomized, controlled trials published in English from 2004 through September 2015.", "score": 0.10060457 }, { "number": 9, "title": "The quality and clinical applicability of recommendations in anxiety disorders guidelines: A systematic review of seventeen guidelines from seven countries - ScienceDirect", "detail": "www.sciencedirect.com", "url": "https://www.sciencedirect.com/science/article/pii/S0165032721009083", "authors": "www.sciencedirect.com", "host": "www.sciencedirect.com", "snippet": "# Review article The quality and clinical applicability of recommendations in anxiety disorders guidelines: A systematic review of seventeen guidelines from seven countries. ### Systematic reviews of clinical practice guidelines: a methodological guide. ### Canadian clinical practice guidelines for ", "score": 0.5798055 }, { "number": 10, "title": "Couple therapy and systemic interventions for adult‐focused ...", "detail": "onlinelibrary.wiley.com", "url": "https://onlinelibrary.wiley.com/doi/10.1111/1467-6427.12481", "authors": "onlinelibrary.wiley.com", "host": "onlinelibrary.wiley.com", "snippet": "Google Scholar\n NICE. (2020) Generalized anxiety disorder and panic disorder in adults management (Clinical guideline 113, published 2011, updated 2020). London: National Institute for Health and Care Excellence.\n\n Google Scholar\n NICE. (2022) Depression in adults: treatment and management (Clinica", "score": 0.4594405 }, { "number": 11, "title": "Panic Disorder and Migraine: Comorbidity, Mechanisms, and ...", "detail": "headachejournal.onlinelibrary.wiley.com", "url": "https://headachejournal.onlinelibrary.wiley.com/doi/10.1111/head.12004", "authors": "headachejournal.onlinelibrary.wiley.com", "host": "headachejournal.onlinelibrary.wiley.com", "snippet": "As is evident from current treatment guidelines outlined in Table 3, no common agents are recommended as first-line treatments for PD and", "score": 0.4504325 }, { "number": 12, "title": "The identification and psychological treatment of panic disorder in ...", "detail": "acamh.onlinelibrary.wiley.com", "url": "https://acamh.onlinelibrary.wiley.com/doi/pdf/10.1111/camh.12372", "authors": "acamh.onlinelibrary.wiley.com", "host": "acamh.onlinelibrary.wiley.com", "snippet": "Preliminary evidence supports the effectiveness of panic disorder-specific treatment in ado- lescents with panic disorder; however, panic disorder may be", "score": 0.3247925 }, { "number": 13, "title": "Antipsychotic agents in anxiety disorders: An umbrella review", "detail": "onlinelibrary.wiley.com", "url": "https://onlinelibrary.wiley.com/doi/full/10.1111/acps.13669", "authors": "onlinelibrary.wiley.com", "host": "onlinelibrary.wiley.com", "snippet": "Treatment guidelines recommend, as first-line pharmacotherapy, the use of SSRIs or SNRIs, while the use of benzodiazepines, TCAs, and other", "score": 0.27801216 }, { "number": 14, "title": "A Network Analysis of Panic Disorder, Agoraphobia, and ...", "detail": "onlinelibrary.wiley.com", "url": "https://onlinelibrary.wiley.com/doi/10.1002/brb3.71241", "authors": "onlinelibrary.wiley.com", "host": "onlinelibrary.wiley.com", "snippet": "GAD is defined by excessive, uncontrollable worry coupled with chronic tension, irritability, fatigue, and sleep disturbance", "score": 0.19223623 }, { "number": 15, "title": "Evaluating the efficacy of psychological therapies for generalised ...", "detail": "acamh.onlinelibrary.wiley.com", "url": "https://acamh.onlinelibrary.wiley.com/doi/10.1002/jcv2.70056", "authors": "acamh.onlinelibrary.wiley.com", "host": "acamh.onlinelibrary.wiley.com", "snippet": "Generalised Anxiety Disorder (GAD) is a common anxiety disorder in youth, and is largely treated with psychological therapies. This systematic", "score": 0.15006647 }, { "number": 16, "title": "Diagnosis and treatment of patients with bipolar disorder", "detail": "onlinelibrary.wiley.com", "url": "https://onlinelibrary.wiley.com/doi/pdf/10.1002/2327-6924.12275", "authors": "onlinelibrary.wiley.com", "host": "onlinelibrary.wiley.com", "snippet": "Purpose: This review article provides an overview of the frequency, burden of illness, diagnosis, and treatment of bipolar disorder (BD) from the", "score": 0.08716692 }, { "number": 17, "title": "Cardiac Anxiety - an overview | ScienceDirect Topics", "detail": "www.sciencedirect.com", "url": "https://www.sciencedirect.com/topics/neuroscience/cardiac-anxiety", "authors": "www.sciencedirect.com", "host": "www.sciencedirect.com", "snippet": "Guaiana et al. (2005) tested the effects of 9 sessions (3 times per week) of low frequency (1 Hz) rTMS over the right PFC (more details on this target region were not reported) of a 34-year-old woman. PD symptoms were assessed via the Panic Disorder Severity Scale (PDSS) (Katherine Shear et al., 199", "score": 0.28241432 }, { "number": 18, "title": "A meta-analysis of the efficacy of psycho- and pharmacotherapy in panic disorder with and without agoraphobia - ScienceDirect", "detail": "www.sciencedirect.com", "url": "https://www.sciencedirect.com/science/article/pii/S0165032705001278", "authors": "www.sciencedirect.com", "host": "www.sciencedirect.com", "snippet": "Title: A meta-analysis of the efficacy of psycho- and pharmacotherapy in panic disorder with and without agoraphobia - ScienceDirect\n# Research report A meta-analysis of the efficacy of psycho- and pharmacotherapy in panic disorder with and without agoraphobia. The efficacy of (cognitive) behavioura", "score": 0.7845341 }, { "number": 19, "title": "Table A4, Characteristics of Included Guidelines - Yoga for the Treatment of Post-Traumatic Stress Disorder, Generalized Anxiety Disorder, Depression, and Substance Abuse: A Review of the Clinical Effectiveness and Guidelines - NCBI Bookshelf", "detail": "www.ncbi.nlm.nih.gov", "url": "https://www.ncbi.nlm.nih.gov/books/NBK304568/table/T5?report=objectonly", "authors": "www.ncbi.nlm.nih.gov", "host": "www.ncbi.nlm.nih.gov", "snippet": "| VA/DoD Clinical Practice Guideline For Management of Post-Traumatic Stress US The Management of Post-Traumatic Stress Working Group, 201036 | Intended users: Healthcare professionals in any VA or DoD clinical setting treating or facilitating services for patients with PTSD. Target population: A", "score": 0.44898248 }, { "number": 20, "title": "Table 1, Current clinical practice guidelines for the treatment of child and adolescent DDs - Treatment of Depression in Children and Adolescents: A Systematic Review - NCBI Bookshelf", "detail": "www.ncbi.nlm.nih.gov", "url": "https://www.ncbi.nlm.nih.gov/books/NBK555846/table/ch2.tab1", "authors": "www.ncbi.nlm.nih.gov", "host": "www.ncbi.nlm.nih.gov", "snippet": "a\n: Authors mention that recommendations can be applied to adolescents with PDD and premenstrual dysphoric disorder as well.\n: AACAP = American Academy of Child and Adolescent Psychiatry; AAP = American Academy of Pediatrics; APA = American Psychological Association; CBT = cognitive behavioral t", "score": 0.42491361 }, { "number": 21, "title": "Table 4, Characteristics of Included Guidelines - Short-Term Psychodynamic Psychotherapy for the Treatment of Mental Illness: A Review of Clinical Effectiveness and Guidelines - NCBI Bookshelf", "detail": "www.ncbi.nlm.nih.gov", "url": "https://www.ncbi.nlm.nih.gov/books/NBK525874/table/app2.t3?report=objectonly", "authors": "www.ncbi.nlm.nih.gov", "host": "www.ncbi.nlm.nih.gov", "snippet": "NICE = National Institute for Health and Care Excellence; VA/DoD = US Department of Veterans Affairs and Department of Defense.\n\nFrom: Short-Term Psychodynamic Psychotherapy for the Treatment of Mental Illness: A Review of Clinical Effectiveness and Guidelines\n\nCover of Short-Term Psychodynamic Psyc", "score": 0.4059909 }, { "number": 22, "title": "Clinical Guidelines on Long-Term Pharmacotherapy for Bipolar Disorder in Children and Adolescents - PMC", "detail": "www.ncbi.nlm.nih.gov", "url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4449672?term=", "authors": "www.ncbi.nlm.nih.gov", "host": "www.ncbi.nlm.nih.gov", "snippet": "Clinical guidelines produced by NICE consist of recommendations on treatment of specific conditions within the NHS in the United Kingdom. They also publish guidance pertaining to public health and interventional procedures, alongside appraisals of medical technology. Their guidance is intended for u", "score": 0.4042963 }, { "number": 23, "title": "Clinical Practice Guidelines for Assessment and Management of ...", "detail": "pmc.ncbi.nlm.nih.gov", "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC10096212", "authors": "pmc.ncbi.nlm.nih.gov", "host": "pmc.ncbi.nlm.nih.gov", "snippet": "Point of care ultrasonography of the lungs, bedside X-ray of the chest, and peak flowmetry to rule out any respiratory abnormalities are advisable. A toxicological screening to rule out any drug abuse is also helpful in an emergency setting. After ruling out the possible physical causes, the patient", "score": 0.49699774 }, { "number": 24, "title": "Panic Disorder: Current Research and Management Approaches - PMC", "detail": "pmc.ncbi.nlm.nih.gov", "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC6354045", "authors": "pmc.ncbi.nlm.nih.gov", "host": "pmc.ncbi.nlm.nih.gov", "snippet": "are as follows: 1) distinction of agoraphobia from panic disorder and 2) defining panic attacks as a specifier. In the DSM-5, a panic disorder diagnosis is operationally defined as the fulfillment of both recurrent unexpected panic attacks (Criterion A) and the existence of one or more of the follow", "score": 0.41577685 } ], "publishedAt": "2026-09-15T17:20:25.610991+00:00", "updatedAt": "2026-09-15T17:20:25.610991+00:00", "readingMinutes": 4, "slug": "panic-disorder" }